![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/05/2924231/37149/en/PDS-Biotech-Announces-Abstract-Accepted-for-Presentation-at-ESMO-Congress-2024.html
https://www.globenewswire.com/news-release/2024/08/01/2922687/37149/en/PDS-Biotech-Aligns-with-FDA-on-Phase-3-Trial-in-HPV16-Positive-First-Line-Recurrent-or-Metastatic-Head-and-Neck-Cancer.html
https://www.globenewswire.com/news-release/2024/07/31/2922208/37149/en/PDS-Biotech-to-Host-Clinical-Program-Update-Conference-Call-on-August-1-2024-at-8-a-m-Eastern-Time.html
https://www.globenewswire.com/news-release/2024/07/29/2920253/37149/en/PDS-Biotech-to-Participate-at-BTIG-Virtual-Biotechnology-Conference.html
https://www.globenewswire.com/news-release/2024/05/15/2882359/37149/en/PDS-Biotech-Provides-Business-Update-and-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/09/2879304/37149/en/PDS-Biotech-VERSATILE-002-Phase-2-Clinical-Trial-Meets-Primary-Study-Endpoints-in-First-Line-Recurrent-Metastatic-HPV16-Positive-Head-and-Neck-Cancer.html
https://www.globenewswire.com/news-release/2024/05/09/2878726/37149/en/PDS-Biotech-to-Participate-in-Upcoming-May-2024-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/07/2876656/37149/en/PDS-Biotech-to-Announce-First-Quarter-2024-Financial-Results-on-May-15-2024.html
https://www.globenewswire.com/news-release/2024/05/03/2875080/37149/en/PDS-Biotechnology-Announces-Details-of-Virtual-KOL-Event.html
https://www.globenewswire.com/news-release/2024/04/23/2867593/37149/en/PDS-Biotech-to-Host-Key-Opinion-Leader-Event-to-Discuss-Positive-Updated-Data-from-Phase-2-VERSATILE-002-Clinical-Trial-with-Versamune-HPV-in-Combination-with-KEYTRUDA-in-Recurrent.html